Spotlight for healthy adolescents and adolescents with preexisting chronic diseases during the COVID-19 pandemic

Silva, Clóvis A.; Queiroz, Lígia Bruni; Fonseca, Claudia de Brito; Silva, Luís Eduardo Vargas da; Lourenço, Benito; Marques, Heloisa

doi:10.6061/clinics/2020/e1931

Cited by 36 publications

(45 citation statements)

References 47 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Sufficient food supply can only be determined in sequential nutritional evaluations including clinical and laboratory findings. ( 15 , 39 ) As previously alluded to, breast milk is a true immunonutrient and its administration must be encouraged.…”

Section: Nutritional Involvement and Recommendationsmentioning

confidence: 99%

Gastrointestinal manifestations and nutritional therapy during COVID-19 pandemic: a practical guide for pediatricians

Oba¹,

Carvalho²,

Silva³

et al. 2020

Einstein (São Paulo)

Self Cite

View full text Add to dashboard Cite

Coronavirus disease 2019 (COVID-19) is a disease caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has spread globally in pandemic proportions. Accumulative evidence suggests SARS-CoV-2 can be transmitted through the digestive system, the so-called fecal-oral route of transmission, and may induce several gastrointestinal manifestations. MEDLINE ® and Embase databases were extensively searched for major clinical manifestations of gastrointestinal involvement in children and adolescents with COVID-19 reported in medical literature, and for nutritional therapy-related data. Findings and recommendations were pragmatically described to facilitate overall pediatric approach. A total of 196 studies addressing gastrointestinal or nutritional aspects associated with the global COVID-19 pandemic were found. Of these, only 17 focused specifically on pediatric patients with regard to aforementioned gastrointestinal or nutritional aspects. Most articles were descriptive and six addressed guidelines, established protocols, or expert opinions. Children and adolescents with gastrointestinal symptoms, such as nausea, vomiting and diarrhea, should be seriously suspected of COVID-19. Gastrointestinal signs and symptoms may occur in 3% to 79% of children, adolescents and adults with COVID-19, and are more common in severe cases. These include diarrhea (2% to 50%), anorexia (40% to 50%), vomiting (4% to 67%), nausea (1% to 30%), abdominal pain (2% to 6%) and gastrointestinal bleeding (4% to 14%). Patients with inflammatory bowel disease or chronic liver disease are not at greater risk of infection by SARS-CoV-2 relative to the general population. Nutritional support plays an important role in treatment of pediatric patients, particularly those with severe or critical forms of the disease. The digestive system may be a potential route of COVID-19 transmission. Further research is needed to determine whether the fecal-oral route may be involved in viral spread. Nutritional therapy is vital to prevent malnutrition and sarcopenia in severe cases.

show abstract

Section: Nutritional Involvement and Recommendationsmentioning

confidence: 99%

Gastrointestinal manifestations and nutritional therapy during COVID-19 pandemic: a practical guide for pediatricians

Oba¹,

Carvalho²,

Silva³

et al. 2020

Einstein (São Paulo)

Self Cite

View full text Add to dashboard Cite

show abstract

“…Pediatric COVID-19 has been reported in Chinese, Italian, Spanish, and US populations, with a frequency ranging from 1.7% to 2% in population-based studies ( 4 , 5 , 7 - 10 ). The vast majority of children and adolescents with COVID-19 are asymptomatic or present with mild or moderate manifestations ( 4 , 5 , 9 , 11 , 12 ). The broad clinical spectrum in pediatric populations includes fever (41-56%), cough (44-54%), dyspnea (11-13%), diarrhea (9-13%), and vomiting (10-11%) (5-9).…”

Section: Introductionmentioning

confidence: 99%

Differences among Severe Cases of Sars-CoV-2, Influenza, and Other Respiratory Viral Infections in Pediatric Patients: Symptoms, Outcomes and Preexisting Comorbidities

Sousa

Sampaio-Carneiro

Carvalho

et al. 2020

Clinics

Self Cite

View full text Add to dashboard Cite

“…Whereas most infected individuals are asymptomatic or experience mild symptoms (e.g., fever, cough, shortness of breath, and myalgia), 10-20% of patients develop acute respiratory distress syndrome (1). Intensive care unit (ICU) length of stay is relatively long, and the need for prolonged orotracheal intubation (X48 hours) is frequent (2,3). Although information is still limited, patients can experience post-acute consequences, including severe muscle weakness and fatigue, joint stiffness, dysphagia, (neuro)psychological problems, and impaired functioning in terms of mobility and activities of daily living (4).…”

mentioning

confidence: 99%

Preliminary results of a clinical study to evaluate the performance and safety of swallowing in critical patients with COVID-19

Lima¹,

Sassi²,

Medeiros³

et al. 2020

Clinics

View full text Add to dashboard Cite

Spotlight for healthy adolescents and adolescents with preexisting chronic diseases during the COVID-19 pandemic

Cited by 36 publications

References 47 publications

Gastrointestinal manifestations and nutritional therapy during COVID-19 pandemic: a practical guide for pediatricians

Gastrointestinal manifestations and nutritional therapy during COVID-19 pandemic: a practical guide for pediatricians

Differences among Severe Cases of Sars-CoV-2, Influenza, and Other Respiratory Viral Infections in Pediatric Patients: Symptoms, Outcomes and Preexisting Comorbidities

Preliminary results of a clinical study to evaluate the performance and safety of swallowing in critical patients with COVID-19

Contact Info

Product

Resources

About